semaglutide diabetes research Market Size, Share and Analysis, 2026-2033 GLP-1 receptor agonists can reduce
Description
(Catch all the Business News, Breaking News, and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online.
Strategies to reduce side effects, such as slow dose escalation, unfortunately do not fully mitigate nausea, vomiting, and gastrointestinal (GI) distress, which are the primary reasons for treatment discontinuation ( 5 )
Your body needs to get used to a steady, weekly dosage schedule
The exact stopping window varies based on whether you use weekly semaglutide injection, oral semaglutide, or compounded formulations from licensed 503A pharmacies
This improvement correlates with meaningful weight reduction, better glycemic control in diabetic patients, and adaptation to the new eating patterns
